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Abstract Shank is a post-synaptic scaffolding protein that has many binding partners. Shank
mutations and copy number variations (CNVs) are linked to several psychiatric disorders, and to
synaptic and behavioral defects in mice. It is not known which Shank binding partners are
responsible for these defects. Here we show that the C. elegans SHN-1/Shank binds L-type calcium
channels and that increased and decreased shn-1 gene dosage alter L-channel current and activity-
induced expression of a CRH-1/CREB transcriptional target (gem-4 Copine), which parallels the
effects of human Shank copy number variations (CNVs) on Autism spectrum disorders and
schizophrenia. These results suggest that an important function of Shank proteins is to regulate
L-channel current and activity induced gene expression.
DOI: 10.7554/eLife.18931.001
Introduction
Shank is a synaptic scaffolding protein (containing SH3, Ankyrin, PDZ, proline-rich and SAM domains)
(Grabrucker et al., 2011). Because Shank is highly enriched in the post-synaptic densities of excit-
atory synapses, prior studies have focused on the idea that Shank proteins regulate some aspect of
synapse formation or function. Through its various domains, Shank proteins bind hundreds of other
synaptic proteins (Lee et al., 2011; Sakai et al., 2011) thereby potentially altering diverse cellular
functions. Shank proteins have been implicated in synaptic transmission, synapse formation, synaptic
plasticity, and cytoskeletal remodeling (Jiang and Ehlers, 2013).
Mammals have three Shank genes, each encoding multiple isoforms (Jiang and Ehlers, 2013).
Several mouse Shank knockouts have been described but these mutants exhibit inconsistent (often
contradictory) synaptic and behavioral defects (Jiang and Ehlers, 2013), most likely resulting from
differences in which Shank isoforms are impacted by each mutation. The biochemical mechanism by
which Shank mutations alter synaptic function and behavior has not been determined.
In humans, Shank mutations and CNVs are linked to Autism Spectrum Disorders (ASD), schizo-
phrenia, and mania (Durand et al., 2007; Pec¸a et al., 2011). Haploinsufficiency for 22q13 (which
spans the Shank3 locus) occurs in Phelan-McDermid syndrome (PMS), a syndromic form of ASD
(Phelan and McDermid, 2012). PMS patients exhibit autistic behaviors accompanied by hypotonia,
delayed speech, and intellectual disability (ID) (Bonaglia et al., 2011). Heterozygous inactivating
Shank3 mutations are found in sporadic ASD and schizophrenia (Durand et al., 2007; Pec¸a et al.,
2011). These genetic studies suggest that decreased Shank3 function likely plays an important role
in the pathophysiology of these psychiatric disorders.
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A parallel set of genetic studies suggest that increased Shank3 function also contributes to psy-
chiatric diseases. 22q13 duplications spanning Shank3 are found in ASD, schizophrenia, ADHD, and
bipolar disorder (Durand et al., 2007; Failla et al., 2007; Han et al., 2013). These 22q13 duplica-
tions involve multiple genes; consequently, the contribution of increased Shank3 to these psychiatric
disorders was uncertain. To address this issue, a transgenic mouse model was developed that selec-
tively over-expresses Shank3 (Han et al., 2013). This transgenic mouse exhibited hyperactive behav-
ior and susceptibility to seizures. Taken together, these studies suggest that too little or too much
Shank3 is associated with several psychiatric disorders.
If Shank3 mutations and CNVs are causally associated with these psychiatric disorders, cellular
and circuit phenotypes should also be sensitive to Shank3 copy number. Consistent with this idea,
several defects have been reported in Shank3+/- heterozygotes, including: decreased mEPSC fre-
quency and spine density (Zhou et al., 2016), decreased Ih current density (Yi et al., 2016),
decreased TRPV1 current density (Han et al., 2016), increased tactile sensitivity (Orefice et al.,
2016), and decreased post-synaptic Homer abundance (Wang et al., 2016). Increased Shank
expression was associated with increased spine density in hippocampus and decreased inhibitory
synapses (Han et al., 2013). In many cases (Han et al., 2013; Orefice et al., 2016; Wang et al.,
2016; Zhou et al., 2016), it was not determined if these phenotypes are a cell autonomous conse-
quence of altered Shank3 copy number. While these studies identify cellular deficits associated with
Shank3 CNVs, it remains unclear which Shank binding partners and cellular functions are responsible
for psychiatric traits, nor why these traits are sensitive to both increased and decreased Shank gene
dosage.
To further investigate how Shank proteins regulate nervous system development and function,
we analyzed Shank function in an invertebrate genetic model. Here we show that C. elegans SHN-1
is a dose-sensitive regulator of Cav1 calcium current and CREB induced gene expression in C. ele-
gans body muscles.
Results
The SHN-1 PDZ domain binds EGL-19/Cav1 channels
C. elegans has a single Shank gene, shn-1. The SHN-1 protein lacks an SH3 domain but has all other
domains found in mammalian Shank proteins (Figure 1A). Many protein ligands have been identified
for the Shank PDZ domain (Lee et al., 2011). Of these potential binding partners, we focused on
EGL-19/Cav1 because human CACNA1C (which encodes a Cav1 a-subunit) is mutated in Timothy
Syndrome (TS), a rare monogenic form of ASD (Splawski et al., 2005, 2004), and polymorphisms
linked to CACNA1C are associated with multiple psychiatric disorders (Cross-Disorder Group of
the Psychiatric Genomics Consortium, 2013). We confirmed that SHN-1’s PDZ domain binds the
EGL-19 carboxy-terminal motif (-VTTLCOOH) by both yeast two-hybrid and GST-pull down assays
(Figure 1—figure supplement 1A and B). Thus, like their mammalian counterparts, SHN-1 binds to
EGL-19/ Cav1 (Zhang et al., 2005).
EGL-19/Cav1 calcium currents are diminished in shn-1 mutants
The impact of Shank binding on Cav1.3 function has been assessed by over-expression in Xenopus
oocytes and in cultured neurons (Stanika et al., 2016; Zhang et al., 2005) but has not been tested
in mutant or transgenic animals. Because shn-1 is expressed in muscles (Stefanakis et al., 2015), we
assayed EGL-19/Cav1 channel function by recording voltage-activated calcium currents in body mus-
cle, using salines containing potassium channel blockers (TEA and 4AP). In these conditions, the
remaining voltage-activated inward current is entirely blocked by the EGL-19 antagonist nemadipine
(Laine´ et al., 2011). In shn-1(tm488) null mutants, calcium current density was significantly decreased
(Figure 1B,C,E). Neither the voltage-dependence of calcium current activation (Figure 1D) nor the
deactivation kinetics (Figure 1F) were altered in shn-1(tm488) null mutants. The shn-1 calcium cur-
rent defect was rescued by a transgene restoring SHN-1 expression in body muscles (Figure 1E),
confirming that SHN-1 has a cell autonomous effect on EGL-19/Cav1 currrent. To determine if SHN-
1’s effects on calcium currents were specific, we measured voltage-activated potassium currents in
body muscles (Figure 1—figure supplement 1C). Neither the voltage-dependence nor the current
density of fast and slow potassium currents were significantly altered in shn-1 mutants. Collectively,
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Figure 1. SHN-1 promotes EGL-19/Cav1 channel function. (A) The protein domains found in SHN-1 and rat
Shank3A are compared. SHN-1 lacks an SH3 domain but contains all other domains found in mammalian Shank
proteins. Homology between the worm and mammalian protein is shown for each domain. (B–F) Voltage-activated
Ca+2 currents were recorded from adult body wall muscles of the indicated genotypes at holding potentials of
 60 to +40 mV. Averaged traces (B), mean current density as a function of holding potential (C), normalized
Figure 1 continued on next page
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these results suggest that SHN-1 specifically regulates the expression or function of EGL-19/Cav1
channels.
SHN-1 binding to EGL-19 increases Cav1 current density
SHN-1 effects on calcium current density could result from direct binding of SHN-1 to EGL-19/Cav1
or indirectly via other SHN-1 binding partners. We did several experiments to distinguish between
these possibilities. First, we utilized CRISPR to isolate two deletion alleles that alter the EGL-19 car-
boxy-terminus (nu495 and nu496) (Figure 2A). Both deletion mutants exhibited decreased calcium
current density (similar to the defect observed in shn-1 null mutants) (Figure 2B–C). The egl-19
(nu496) mutation had no effect on the voltage-dependence of calcium current activation nor on
deactivation kinetics (Figure 2—figure supplement 1A and B). The egl-19(nu496) and shn-1 null
mutations did not have additive effects on calcium current density in double mutants, as would be
predicted if SHN-1’s effects on calcium current require direct binding to EGL-19’s carboxy-terminus
(Figure 2D and E). To further examine the functional impact of the SHN-1 PDZ interaction with EGL-
19, we analyzed shn-1(ok1241) mutants, which have an in-frame deletion spanning exons encoding
the PDZ domain and part of the proline-rich domain (Figure 1—figure supplement 1D). The shn-1
(ok1241) mutants exhibited a decrease in calcium current density similar to those observed in shn-1
null and the egl-19 carboxy-terminal deletion mutants and had no effect on voltage-dependence of
current activation nor on deactivation kinetics (Figure 2—figure supplement 1C–F). Collectively,
these results suggest that SHN-1 binding to EGL-19’s carboxy-terminus promotes the expression or
function of L-type calcium channels.
SHN-1 promotes trafficking of EGL-19 channels to the cell surface
SHN-1 effects on calcium current could result from a change in EGL-19 delivery to the cell surface.
We performed two further experiments to test this idea. First, we measured the gating currents of
voltage-activated channels in body muscles (Figure 3A–B). The activation of Cav channels is medi-
ated by depolarization-induced movements of positively charged residues in membrane-spanning S4
helices, which are termed gating charges. When there is no net calcium current (by holding the mus-
cle membrane at the reversal potential), gating charge movement can be measured as a small volt-
age-activated current. The magnitude of gating currents can be used as a measure of Cav channel
surface abundance (Fu et al., 2011; Hulme et al., 2006). The total voltage activated gating charge
in body muscles was significantly reduced in shn-1 null mutants (Figure 3B). This shn-1 mutant defect
in gating charge is unlikely to result from decreased surface delivery of other voltage-activated chan-
nels because voltage-activated potassium currents were unaltered in shn-1 mutants (Figure 1—fig-
ure supplement 1C). Thus, analysis of gating currents suggests that the decreased calcium current
exhibited in shn-1 mutants arises from decreased trafficking of EGL-19/Cav1 channels to the cell
surface.
To further investigate SHN-1’s effects on EGL-19 trafficking, we designed a fluorescent reporter
construct containing a trans-membrane domain fused to EGL-19’s cytoplasmic tail domain (504
amino acids), which includes the carboxy-terminal PDZ ligand (Figure 3C). This chimeric protein (des-
ignated Terrier to indicate the presence of EGL-19’s cytoplasmic tail) was expressed in body
muscles. The Terrier protein contains tagRFP in the cytoplasmic domain, and pHluorin (a pH-
Figure 1 continued
conductance as a function of holding potential (D), mean current density at 10 mV (E), and mean deactivation time
constants (F) are shown. shn-1 mutants had significantly decreased Ca+2 current-density and this defect was
rescued by a single copy transgene expressing SHN-1 in body muscles (nuSi26) (D). No significant differences were
observed for voltage-dependence of current activation and de-activation kinetics. The number of animals analyzed
is indicated for each genotype. Values that differ significantly from wild type controls are indicated (***p<0.001).
Error bars indicate SEM. Mean, standard errors, sample sizes, and p values for this figure are shown in
Supplementary file 1.
DOI: 10.7554/eLife.18931.002
The following figure supplement is available for figure 1:
Figure supplement 1. Supplemental data related to Figure 1.
DOI: 10.7554/eLife.18931.003
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Figure 2. SHN-1 binding to EGL-19’s carboxy-terminus promotes the expression or function of L-type calcium
channels. (A) Predicted c-terminal sequences of mutant EGL-19 proteins are shown. egl-19(nu496) is a 22 bp
deletion and egl-19(nu495) is a 5 bp deletion, both resulting in frame shifts that delete the carboxy-terminal PDZ
ligand of EGL-19 (-VTTLCOOH). Residues in blue represent the PDZ ligand. Residues in red represent those
introduced by the frame shift mutations. (B–E) Voltage-activated Ca+2 currents were recorded from adult body wall
muscles of the indicated genotypes at holding potentials of  60 to +40 mV. Representative traces (B), mean
current density at 0 mV (C, E), and mean current density as a function of holding potential (D) are shown. The egl-
19(nu496) and shn-1(tm488) single mutants had similar decreases in Ca+2 current-density, and additive defects
were not observed in the double mutant. The number of animals analyzed is indicated for each genotype. Values
that differ significantly from wild type controls are indicated (***p<0.001). Error bars indicate SEM. Mean, standard
errors, sample sizes, and p values for this figure are shown in Supplementary file 1.
DOI: 10.7554/eLife.18931.004
The following figure supplement is available for figure 2:
Figure supplement 1. Supplemental data related to Figure 2.
DOI: 10.7554/eLife.18931.005
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sensitive GFP) in the ectodomain (Figure 3C). Thus, red fluorescence reports total Terrier protein
while green fluorescence reports surface Terrier molecules. When expressed in body muscles, Terrier
exhibits a punctate green and red fluorescence in the nerve ring, where body muscles receive synap-
tic input (Figure 3C–D). In shn-1 null mutants, the intensity and size of green Terrier puncta were sig-
nificantly decreased (Figure 3D–G), indicating decreased surface Terrier protein in the nerve ring.
Thus, decreased calcium current density (20%) in shn-1 mutants was mirrored by similar decreases in
gating charge (26%) and total surface Terrier fluorescence (36%). Collectively, these results suggest
that the decreased calcium current in shn-1 null mutants arises from decreased delivery of EGL-19/
Cav1 channels to the cell surface.
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Figure 3. SHN-1 promotes EGL-19/Cav1 delivery to the cell surface. (A–B) Voltage-activating gating currents were significantly decreased in shn-1 null
mutants. Averaged trace of gating current in wild type adult body muscles (A) and mean gating charge (normalized to capacitance) (B) are shown. (C–
G) Surface delivery of the Terrier fusion protein is significantly reduced in shn-1 null mutants. (C) A schematic illustrating the structure of the Terrier
fusion protein is shown. (D) A schematic illustrating the imaged region (left) and representative images of Terrier pHluorin fluorescence in the nerve ring
are shown. Mean pHluorin puncta intensity (E), pHluorin puncta area (F), and total pHluorin puncta fluorescence (G) are shown. Regions of interest
utilized to quantify Terrier fluorescence are indicated (D). The number of animals analyzed is indicated for each genotype. Values that differ significantly
from wild type controls are indicated (**p<0.01, *p<0.05). Error bars indicate SEM.
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gem-4 is an activity-induced CRH-1/CREB target expressed in muscles
Increased cytoplasmic calcium activates expression of a large number genes, hereafter designated
activity-induced gene expression. Although Cav1 channels account for a small fraction of bulk cal-
cium entry in neurons, Cav1 channels account for the majority of activity-induced gene expression
(Ma et al., 2012). This privileged ability of Cav1 channels to activate gene expression is thought to
be mediated by direct physical coupling of Cav1 channels to the calcium sensors responsible for
activating CREB (Deisseroth et al., 1996; Wheeler et al., 2008).
Because shn-1 mutations alter EGL-19/Cav1 current, we hypothesized that SHN-1 may also play a
role in activity-induced gene expression. To test this idea, we first identified activity-induced muscle
genes. We analyzed gene expression following depolarization of body muscles with a nicotinic ace-
tylcholine (ACh) agonist (levamisole, Lev). Lev-induced genes were identified using the Affymetrix C.
elegans gene chip. This analysis identified 427 genes whose expression was significantly increased
following muscle depolarization (>2 fold change, FDR p<0.05) (Figure 4, Supplementary file 2).
67% (287/427) of Lev-induced genes contain binding sites for the myogenic transcription factor
HLH-1 (<5 kb from the transcriptional start site, TSS) in chromatin-immunoprecipitation experiments
(http://www.modencode.org), suggesting that these genes are expressed in body muscles. Of the
HLH-1 binding genes, 81% (233/287) contain predicted CREB binding sites (<5 kb from the TSS).
These results suggest that C. elegans body muscles (like other excitable cells) have a large number
of activity-induced genes, many of which are potential CREB transcriptional targets.
Using this Lev-induced gene list, we devised a simple reporter assay for CREB induced gene
expression. For this purpose, we focused on the gem-4/Copine gene, which was the top hit from
our analysis of Lev-induced genes (induced ~30 fold) (Figure 4). The gem-4 promoter contains
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Figure 4. Analysis of mRNA abundance following muscle depolarization. mRNA abundance in Lev (200 mM, 1 hr)
versus mock treated synchronized L4 larvae is plotted. Fold change (x-axis) is plotted against the statistical
significance (y-axis) for each probeset. Fold changes are shown in log2 scale. Adjusted P values are shown in -
log10 scale. Genes with increased (red dots) and decreased (green dots) expression are indicated (>2 Fold-change,
FDR p<0.05). Probe sets corresponding to gem-4 and cex-1 are indicated. All genes that are differentially
expressed following Lev treatment are listed in Supplementary file 2.
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multiple CRH-1/CREB binding sites, implying that it could be a direct CRH-1 transcriptional target.
Quantitative RT-PCR confirmed that Lev treatment increased gem-4 mRNA levels 8-fold (Figure 5A).
We designed a transcriptional reporter (Figure 5B) that compares expression of the gem-4 pro-
moter (expressing NLS-GFP) with a control promoter unaffected by depolarization (the myo-3 pro-
moter, expressing NLS-mCherry) in individual muscle cells. Using this reporter, we found that Lev
treatment increased gem-4 expression 8–12-fold (Figure 5C–D) while myo-3 expression was unal-
tered (Figure 5—figure supplement 1A). Lev-induction of the gem-4 reporter was eliminated by
mutations inactivating a Lev receptor subunit (UNC-29), indicating that gem-4 induction was not
mediated by an off target effect of Lev (Figure 5C). Lev-induction of gem-4 was also blocked in
mutants lacking CRH-1/CREB and this defect was rescued by a transgene expressing CRH-1 in body
muscles (Figure 5D). These results identify gem-4 as a CRH-1/CREB target expressed in body
muscles.
Lev treatment is a non-physiological stimulus that produces prolonged muscle depolarization. To
determine if synaptic activity induces the gem-4 reporter, we evoked excitatory synaptic input to
muscles by photo-stimulating transgenic animals expressing channel rhodopsin in cholinergic motor
neurons (Figure 5E). In patch clamp recordings of body muscles, spontaneous action potentials are
observed at ~1 Hz (Gao and Zhen, 2011). Therefore, to mimic a realistic pattern of synaptic input,
we photo-stimulated motor neurons (25 ms light pulse) at 1–20 Hz for 20 min. The gem-4 reporter
was significantly induced following 2, 5, 10, and 20 Hz photo-stimulation (Figure 5E). Induction was
not observed at lower frequencies (0.5 and 1 Hz) nor when animals were cultured without all trans-
retinal (ATR) (Figure 5E). Photo-induction of gem-4 expression was eliminated in unc-13 mutants
(Figure 5—figure supplement 1B), which have dramatically reduced synaptic vesicle exocytosis
(Richmond et al., 1999). By contrast, unc-13 mutations did not prevent Lev-induced gem-4 expres-
sion (Figure 5—figure supplement 1C). Similar levels of gem-4 induction were produced by 20 Hz
photo-stimulation and Lev treatment (Figure 5—figure supplement 1B–C). Thus, the gem-4
reporter was induced by both synaptic and Lev-evoked muscle depolarization. Expression of a
mouse gem-4 paralog (N-copine) in hippocampal neurons is also induced by high frequency stimula-
tion of acute brain slices (Nakayama et al., 1998); consequently, activity-induced copine expression
is observed in both muscles and neurons and is conserved across phylogeny.
SHN-1 is required for gem-4 induction
Using this gem-4 reporter construct, we next asked if SHN-1 is required for CRH-1/CREB-induced
gene expression. Lev-induced gem-4 expression was significantly decreased in shn-1(tm488) null
mutants (Figure 5F). To determine if SHN-1 controls expression of other activity-induced genes, we
developed a transcriptional reporter for a second Lev-induced gene (cex-1) (Figures 4 and
5I). Expression of the cex-1 reporter in body muscles was dramatically induced following Lev treat-
ment (Figure 5J). Because baseline cex-1 expression in untreated muscles could not be reliably
detected, we were unable to accurately measure the fold-induction of the cex-1 reporter following
Lev treatment. As seen with the gem-4 reporter, we found that Lev-induced cex-1 expression in
muscles was dramatically reduced in shn-1 null mutants (Figure 5J). Taken together, these results
support the idea that SHN-1 promotes activity-induced gene expression in body muscles.
Next we asked if gem-4 induction requires binding of SHN-1’s PDZ domain to EGL-19’s carboxy-
terminus. Deleting EGL-19’s PDZ ligand [in egl-19(nu496) mutants] significantly increased gem-4
induction while deleting SHN-1’s PDZ domain [in shn-1(ok1241) mutants] had no effect on gem-4
induction (Figure 5G–H). These results indicate that SHN-1 regulates EGL-19/Cav1 current and CRH-
1/CREB activation by distinct mechanisms, since the former requires PDZ binding to EGL-19 while
the latter does not.
Calcium current and gem-4 induction are sensitive to shn-1 gene dose
Deletion and duplication of human shank genes are both associated with ASD, schizophrenia, and
mania (Bonaglia et al., 2006; Durand et al., 2007; Failla et al., 2007; Gauthier et al., 2010;
Han et al., 2013). If Shank CNVs are causally associated with these psychiatric disorders, cellular
phenotypes should be similarly sensitive to Shank copy number. To test this idea, we analyzed the
effect of shn-1 gene dosage on calcium currents and Lev-induced gem-4 expression (Figure 6). We
analyzed animals with 0 (tm488 homozygotes), 1 (tm488/+ heterozygotes), 2 (WT), and 4 (WT +2
Pym et al. eLife 2017;6:e18931. DOI: 10.7554/eLife.18931 8 of 21
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Figure 5. gem-4 Copine expression in body muscle is induced by depolarization. Induction of gem-4 expression
was analyzed by qPCR (A) and using a transcriptional reporter (B–H). (A) The abundance of gem-4 mRNA
(assessed by qPCR) was increased following 1 hr levamisole (Lev) exposure. The number of biological replicates is
indicated. (B) A schematic diagram of the gem-4 reporter construct (left) and representative images of muscle
Figure 5 continued on next page
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single copy shn-1 transgenes) copies of shn-1. Compared to wild type controls, muscle calcium cur-
rent density was significantly increased in animals containing 1 and 4 copies of shn-1 and was signifi-
cantly decreased in animals containing 0 copies of shn-1 (Figure 6A–C). The kinetics of calcium
current deactivation were not significantly altered by changes in shn-1 dosage (Figure 6D). Similarly,
when compared to wild type controls, gem-4 induction was significantly diminished in animals con-
taining 0, 1, and 4 shn-1 copies (Figure 6E). Thus, L-type calcium current density and gem-4 induc-
tion were both sensitive to shn-1 copy number. Interestingly, increased and decreased shn-1 gene
dosage produced similar defects in calcium current and gem-4 induction.
Cholinergic transmission is not sensitive to shn-1 gene dosage
To determine SHN-1’s role in synaptic transmission, we recorded excitatory post-synaptic currents
(EPSCs) from body muscles. Evoked responses were significantly larger in shn-1 null mutants
(Figure 7A,C). The shape of evoked responses in wild type and shn-1 mutants were indistinguish-
able, indicating that the kinetics of evoked release was unaltered (Figure 7B). The rate and ampli-
tude of spontaneous miniature EPSCs (mEPSCs) were unaltered in shn-1 mutants (Figure 7—figure
supplement 1A–C). The change in evoked EPSC amplitude combined with unaltered mEPSC ampli-
tudes indicates a pre-synaptic change in cholinergic transmission. The shn-1 null EPSC defect was
rescued by transgenes expressing SHN-1 in body muscles, implying that SHN-1 functions post-syn-
aptically (Figure 7B). The evoked EPSCs (Figure 7C) and mEPSCs (Figure 7—figure supplement
1D–E) observed in animals with 1, 2, and 4 shn-1 copies were not significantly different, indicating
that synaptic transmission is not sensitive to shn-1 copy number. Similar results were recently
reported in mice where glutamatergic transmission in the striatum was enhanced in Shank3B-/-
homozygotes but this effect was not observed in Shank3B+/- heterozygotes (Peixoto et al., 2016).
Discussion
Because Shank proteins are highly enriched at post-synaptic densities, prior studies focused on the
idea that Shank regulates synapse formation or function in some manner (Jiang and Ehlers, 2013).
Here we provide evidence that Shank regulates Cav1 calcium current density and activity-induced
gene expression, and that these two cellular functions are mediated by distinct dosage-sensitive
mechanisms.
SHN-1 promotes EGL-1/Cav1 channel delivery to the cell surface
We find that SHN-1’s PDZ domain binds the EGL-19/Cav1 carboxy-terminus (like their mammalian
counterparts) and that disrupting this interaction decreased muscle calcium current. Mutations
Figure 5 continued
nuclei (right) before and after a 20 min Lev exposure, and 2 hr recovery. (C–D) The mean fold induction of the
gem-4 reporter (Pgem-4) after Lev treatment is shown. Lev-induced gem-4 expression was abolished in mutants
lacking UNC-29, an essential subunit of the Lev receptor (C) and in mutants lacking the transcription factor CRH-1
(D). The crh-1 mutant defect in gem-4 induction was rescued by a transgene expressing CRH-1 in body muscles
(D). (E) Expression of the gem-4 reporter was measured following photo-stimulation of transgenic animals that
express ChR2 in cholinergic motorneurons. Expression of gem-4 was significantly increased by 2, 5, 10, and 20 Hz
photo-stimulation (for 20 min). Photo-evoked gem-4 expression was not observed when animals were not cultured
with ATR. (F–G) The fold induction of the gem-4 reporter following Lev exposure was significantly reduced in shn-1
null mutants (F) but not in shn-1(ok1241) mutants, which lack the PDZ domain (G). Lev-induced gem-4 expression
was significantly increased in egl-19(nu496) mutants, which lack the carboxy-terminal PDZ ligand (H). (I–J) Lev
induction of the cex-1 reporter is significantly reduced in shn-1 mutants. (I) Schematics of the cex-1 and myo-3
reporters are shown. (J) Expression of the cex-1 reporter (normalized to myo-3 expression in the same nucleus)
was significantly increased by Lev treatment. The Lev-induced expression of the cex-1 reporter was significantly
reduced in shn-1 mutants. The number of animals analyzed is indicated for each genotype. Values that differ
significantly from wild type controls are indicated (***p<0.001; **p<0.01; *p<0.05). Error bars indicate SEM.
DOI: 10.7554/eLife.18931.008
The following figure supplement is available for figure 5:
Figure supplement 1. Supplemental data related to Figure 5.
DOI: 10.7554/eLife.18931.009
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Figure 6. shn-1 gene dosage regulates calcium current density and gem-4 induction. The effect of varying shn-1
gene dosage on calcium current density (A–B) and gem-4 induction (C) was analyzed. The following genotypes
were analyzed: 0 copies of shn-1 [shn-1(tm488) homozygotes], 1 copy of shn-1 [shn-1(tm488)/+ heterozygotes], 2
copies of shn-1 (wild-type) and 4 copies of shn-1 (nuSi26 homozygotes in wild-type). (A–B) Muscle Ca+2 current was
sensitive to changes in shn-1 gene dose, with decreased (0 shn-1 copies) and increased (1 and 4 shn-1 copies)
current density observed in the indicated genotypes. Mean current density as a function of holding potential (A),
mean current density at 10 mV (B), and mean current deactivation time constants (C) are shown. (D) Lev-induced
gem-4 expression was significantly reduced in animals with 0, 1, and 4 copies of shn-1. The number of animals
analyzed is indicated for each genotype. Values that differ significantly from wild type controls are indicated
(***p<0.001; **p<0.01). Error bars indicate SEM. Mean, standard errors, sample sizes, and p values for panels A-C
are shown in Supplementary file 1.
DOI: 10.7554/eLife.18931.010
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deleting SHN-1’s PDZ domain and those deleting EGL-19’s PDZ ligand both decreased EGL-19 cal-
cium current and additive defects were not observed in double mutants. These results suggest that
SHN-1’s effects on calcium current are mediated by binding of its PDZ domain to EGL-19’s carboxy-
terminus. Analysis of gating currents and Terrier reporter fluorescence suggest that the decreased
muscle calcium currents in shn-1 mutants arises primarily from decreased trafficking of EGL-19/Cav1
channels to the plasma membrane.
Shank effects on Cav1 current in mammalian neurons or muscles have not been reported. The car-
boxy-terminus of mammalian Cav1.3 (-ITTLCOOH) and Cav1.2 (-VSSLCOOH) channels are both pre-
dicted to bind PDZ domains (Zhang et al., 2005). When mutant constructs lacking the carboxy-
terminal PDZ ligands of Cav1.3 or Cav1.2 channels were expressed in hippocampal neurons, no
changes in calcium current were observed; however, the Cav1.3 truncation mutant exhibited
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Figure 7. Synaptic transmission at the NMJ is not sensitive to shn-1 gene dosage. Stimulus-evoked EPSCs were
recorded from adult body wall muscles. Representative traces of evoked responses (A), averaged shn-1 and WT
evoked responses (normalized to equal amplitudes) (B), and mean evoked charge transfer (C) are shown. Evoked
charge was significantly increased in shn-1 homozygotes and this defect was rescued by a single copy transgene
(nuSi26) that restored SHN-1 expression in body muscles (C). Averaged peak normalized shn-1 and WT evoked
responses have indistinguishable rise and decay times, indicating that rise and decay kinetics were unaltered (B).
Evoked charge transfer (D) and peak amplitudes (E) did not differ significantly in animals containing 1, 2, and 4
shn-1 copies. The number of animals analyzed is indicated for each genotype. Values that differ significantly from
wild type controls are indicated (**p<0.01; ns, not significant). Error bars indicate SEM. Mean, standard errors,
sample sizes, and p values for this figure are shown in Supplementary file 1.
DOI: 10.7554/eLife.18931.011
The following figure supplement is available for figure 7:
Figure supplement 1. shn-1 mutations and gene dosage had no effect on mEPSCs.
DOI: 10.7554/eLife.18931.012
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decreased synaptic localization (Weick et al., 2003; Zhang et al., 2005). The rat Shank 1 and 3 PDZ
domains exhibit strong binding to Cav1.3 (but not Cav1.2). Thus, Shank proteins could promote syn-
aptic targeting of Cav1.3; however, the PDZ protein responsible for Cav1.3 targeting has not been
identified. These studies relied on over-expression of mutant Cav1 channels (rather than knockin
mutations altering the endogenous genes); consequently, it remains possible that Shank proteins
could also regulate Cav1 current in mammalian neurons or muscles.
SHN-1 promotes activity-induced expression of gem-4
Prior studies of mammalian neurons proposed that Cav1 channel binding to a PDZ scaffolding pro-
tein promotes activity-induced CREB phosphorylation (Weick et al., 2003; Zhang et al., 2005).
These studies showed that deleting the carboxy-terminal PDZ ligand in Cav1.2 or 1.3, or over-
expressing peptides containing the PDZ-ligands diminish activity-induced CREB phosphorylation and
transcription of CREB targets. The PDZ protein responsible for these effects was not identified in
these studies. Here we show that SHN-1 promotes expression of a CRH-1/CREB transcriptional tar-
get in muscles but that this effect does not require binding of SHN-1’s PDZ domain to EGL-19’s car-
boxy-terminus. In fact, deleting EGL-19’s PDZ ligand significantly enhanced depolarization induced
CRH-1/CREB target expression, perhaps by disrupting EGL-19 interaction with another protein.
Our results suggest that SHN-1’s effects on calcium current density and gem-4 induction are
mediated by distinct mechanisms. Increased calcium current is mediated by SHN-1’s PDZ domain
binding to EGL-19’s carboxy-terminus whereas another SHN-1 domain (most likely the Ankyrin or
Proline-rich domains) enhances CREB activation.
A puzzling aspect of our results is that calcium current density and induced gem-4 expression
were poorly correlated. For example, reduced gem-4 induction was observed in mutants with
decreased (shn-1 null mutants) and increased (shn-1/+ heterozygotes) EGL-19/Cav1 current density.
Similar results were also reported in cultured mammalian neurons, where CREB phosphorylation was
poorly correlated with calcium current density and instead was better correlated with Cav1 open
probability (Wheeler et al., 2008). Based on these results (and others), these authors proposed that
CREB phosphorylation is mediated by a calcium sensor that is spatially very close to (and possibly
physically associated with) activated Cav1 channels (Deisseroth et al., 1996; Wheeler et al., 2008).
In this scenario, CREB phosphorylation would be strongly correlated with calcium levels in the nano-
domain of a Cav1 channel but less correlated with global cytoplasmic calcium. Thus, our results sug-
gest that CRH-1 activation may also be mediated by tight coupling of a calcium sensor to activated
EGL-19/Cav1 channels.
Implications for understanding psychiatric disorders
In humans, Shank deletions and duplications both confer risk for ASD and schizophrenia
(Bonaglia et al., 2006; Durand et al., 2007; Failla et al., 2007; Gauthier et al., 2010; Han et al.,
2013). Thus, too little or too much Shank is associated with psychiatric traits. If Shank CNVs are caus-
ally linked to these psychiatric disorders, cellular defects linked to ASD should exhibit similar sensitiv-
ity to Shank gene dosage. Consistent with this idea, several studies previously reported cellular and
behavioral defects in Shank3m/+ heterozygotes (Han et al., 2016; Orefice et al., 2016; Wang et al.,
2016; Yi et al., 2016). Increased Shank3 copy number has been analyzed in a single study
(Han et al., 2013), which reported several behavioral and synaptic phenotypes. None of these stud-
ies identified phenotypes that were shared between decreased and increased Shank3 dosage. In
most cases, it was not determined if cellular defects were cell autonomous consequences of altered
Shank3 dosage (Han et al., 2013; Orefice et al., 2016; Wang et al., 2016; Zhou et al., 2016). Here
we find that changes in shn-1 gene dosage alter two cell autonomous phenotypes in muscles:
L-channel calcium current and expression of CREB target genes. For both phenotypes, similar
defects were observed in muscles with decreased and increased shn-1 dosage. Thus, we identify two
cellular phenotypes that exhibit the same pattern of dose sensitivity that is observed for Shank3 in
schizophrenia and ASD. Based on these results, we propose that human Shank CNVs also cause cel-
lular phenotypes, which may include altered calcium current and CREB target expression. By con-
trast, other shn-1 mutant phenotypes (e.g. evoked EPSCs) were not sensitive to shn-1 gene dosage.
Thus, sensitivity to Shank copy number provides a useful criterion to determine which phenotypes
are more likely to contribute to the psychiatric traits associated with Shank CNVs. Two recent studies
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showed that Shank3 binds directly to Ih and TRPV1 channels in neurons and that the corresponding
currents densities are significantly reduced in Shank3+/- heterozygotes (Han et al., 2016; Yi et al.,
2016). These results (together with those reported here) suggest that an important function of
Shank proteins is to regulate ion channel densities.
How does shn-1 dose alter L-current and CREB target expression? In general, dosage sensitive
phenotypes are thought to occur by disrupting the function of multimeric protein complexes. In such
cases, under and over-expression of individual subunits alter the stoichiometry of assembled holo-
complexes, leading to decreased activity. For example, increased and decreased expression of the
yeast histones H2A and H2B results in similar loss of function phenotypes (chromosome loss and
altered gene expression) (Clark-Adams et al., 1988; Meeks-Wagner and Hartwell, 1986). Shank
binds many other synaptic proteins (Lee et al., 2011; Sakai et al., 2011) and undergoes zinc
induced polymerization into large complexes (Baron et al., 2006; Hayashi et al., 2009). Thus,
increased and decreased Shank abundance could disrupt the stoichiometry of post-synaptic com-
plexes. Our results suggest that L-current and CREB activation are sensitive to subtle changes in the
stoichiometry of Shank protein complexes. Our results further suggest that dynamic changes in the
composition of Shank complexes provides a mechanism to regulate circuit function and plasticity
(and potentially psychiatric traits).
Shank regulation of L-currents and CREB activation could both contribute to the pathophysiology
of ASD. Human Shank mutations are particularly linked to ASD associated with intellectual disability
(Leblond et al., 2014). CREB has long been linked to learning and memory in several model organ-
isms (Bourtchuladze et al., 1994; Dash et al., 1990; Yin et al., 1994); consequently, Shank’s CREB
activation function could directly contribute to cognitive deficits associated humans Shank CNVs.
CREB-induced BDNF expression promotes development of inhibitory synapses in the cortex
(Hong et al., 2008). Thus, Shank’s CREB activation function could alter synaptic inhibition, a pheno-
type found in several ASD models (Dani et al., 2005; Rubenstein and Merzenich, 2003). Finally,
L-channels play an important role in calcium signaling in dendrites and spines (Higley and Sabatini,
2012). Thus, Shank’s Cav1 current density function could contribute to cognitive or developmental
defects in ASD by adjusting dendritic calcium signaling in CNS neurons. For these reasons, we pro-
pose that Shank effects on Cav1 currents and CREB target expression could play an important role
in the pathophysiology of ASD (and potentially other psychiatric disorders).
Materials and methods
Experimental procedures
Strains
Strain maintenance and genetic manipulation were performed as described (Brenner, 1974). Ani-
mals were cultivated at room temperature (~22˚C) on agar nematode growth media seeded with
OP50 bacteria. The following strains were used in this study:
KP7624 nuIs525[Pgem-4::NLS-GFP; Pmyo-3::NLS-mCherry] V
KP7598 unc-29(x29) I; nuIs525 V
KP7583 crh-1(tz2) III; nuIs525 V
KP7601 oxSi91[Punc17::ChIEF::mCherry] II; nuIs525 V
KP7618 unc-13(s69) I; nuIs525 V
KP7896 unc-13(s69) I; oxSi91 II; nuIs525 V
KP7032 shn-1(tm488) II
KP7272 shn-1(ok1241) II
KP7461 nuSi26[Pmyo-3::shn-1] shn-1(tm488) II
KP7573 shn-1(tm488) II; nuIs525 V
KP7574 bli-2(e768) shn-1(tm488) II; nuIs525 V
KP7567 nuSi26 II; nuIs525 V
KP7493 nuSi26 II
KP7212 bli-2(e768) shn-1(tm488) II
KP7992 egl-19(nu496) IV
KP7997 egl-19(nu496) IV; nuIs525 V
KP8046 shn-1(tm488) II; egl-19(nu496) IV
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KP8047 shn-1(tm488) II; egl-19(nu496) IV; nuIs525 V
KP7991 egl-19(nu495) IV
KP8303 nuSi74 [Pmyo-3::Terrier]
KP8304 nuSi74; shn-1(tm488)
KP8274 nuSi66 [Pmyo-3::NLS::TagBFP2]; nuSi67 [Pcex-1::NLS::mNeonGreen]; nuSi70[Pgem-4::NLS::
tagRFPt]
KP8301 nuSi66;nuSi67;nuSi70;shn-1(tm488)
Transgenic animals were prepared by microinjection, and integrated transgenes were isolated fol-
lowing UV irradiation, as described (Dittman and Kaplan, 2006). Single copy transgenes were iso-
lated by the MoSCI and miniMoS techniques (Frøkjaer-Jensen et al., 2008; Frøkjær-Jensen et al.,
2014).
shn-1 dosage experiments
Animals with different shn-1 copy numbers were constructed as follows: 0 copies, shn-1(tm488)
homozygotes; 1 copy, WT males were crossed with bli-2 shn-1(tm488) homozygotes [KP7212 (for
electrophysiology) and KP7574 (for gem-4 induction)] and non-Blister F1 hermaphrodites were ana-
lyzed; 2 copies, WT males were crossed with bli-2 homozygotes and non-Blister F1 hermaphrodites
were analyzed; 4 copies, WT animals homozygous for the single copy transgene nuSi26. gem-4
reporter expression in bli-2/+ heterozygotes and WT controls did not differ significantly and were
pooled for 2 copies of shn-1.
Constructs and transgenes
Pgem-4 reporter
2 kb of 5’ non-coding sequences from the gem-4 gene was cloned into a vector expressing NLS-
GFP (pPD122.56). A myo-3 promoter region (2.3 kb) was sub-cloned into a vector expressing NLS-
mCherry. Both were injected into WT animals at 5 ng/ml and stable arrays picked. A single extrachro-
mosomal array was integrated by UV irradiation and outcrossed six times (nuIs525).
Pcex-1 reporter
KP#3310 has the cex-1 promoter (1038 bp), a single SV40 NLS, mNeonGreen (Shaner et al., 2013)
(codon optimized for C. elegans) followed by the EGL-13 NLS and the cex-1 3’ UTR (2097bp)
inserted between the SacII and PstI sites of pCFJ1662. A single hygromycin resistant integrant,
nuSi67 was obtained as described (Frøkjær-Jensen et al., 2014). cex-1 reporter expression in each
muscle nucleus was normalized to BFP expressed in the same nucleus (using the myo-3 promoter).
myo-3 expression of BFP
KP#3309 has the myo-3 promoter (2386 bp), a single SV40 NLS, mTagBFP2 (Subach et al., 2011)
(codon optimized for C. elegans) followed by the EGL-13 NLS and the unc-54 3’ UTR inserted
between the SbfI and SnaBI sites of pCFJ901. A single G418 resistant integrant, nuSi66 was
obtained and mapped within the abch-1 gene on Chromosome II as described (Frøkjær-
Jensen et al., 2014).
Terrier
KP#3308 has the myo-3 promoter, PAT-4 signal sequence (from pPD122.36 Addgene), super-ecliptic
pHluorin (Dittman and Kaplan, 2006), PAT-3 transmembrane domain (pPD122.36) followed by the
cDNA of EGL-19B coding for residues 1374–1872, tagRFP-T (codon optimized for C. elegans), and
the cDNA of EGL-19B coding for residues 1873–1877, followed by the let-858 3’ UTR (pPD122.36)
inserted between the HindIII and AflII sites in the polylinker of the miniMOS vector pCFJ910
(Addgene).
Single copy insertions of Terrier were obtained using the miniMOS technique as described (Frøk-
jær-Jensen et al., 2014).
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shn-1 rescue
A C33B4.3a cDNA was cloned using gateway into DONR221. Multisite gateway was used to assem-
ble Pmyo-3::shn-1::unc54UTR into pCFJ150 and a single copy transgene (nuSi26) was obtained by
injecting EG6699. The unc-119(ed3) allele was outcrossed from nuSi26 prior to analysis.
Fluorescence imaging
Confocal imaging was performed using an Olympus 60x objective (NA 1.45) on an Olympus FV-1000
confocal microscope at 5x digital zoom. For Pgem-4 imaging, ~15 worms were exposed to 1 mM
Lev for 20 mins. Two hours after Lev stimulation, worms were immobilized on 10% agarose pads
with 0.3 ml of 0.1 mm diameter polystyrene microspheres (Polysciences 00876–15, 2.5% w/v suspen-
sion). Individual muscle nuclei were imaged next to the terminal bulb of the pharynx and analysed
using FIJI (https://fiji.sc). The ratio was obtained of green (Pgem-4) to red (Pmyo-3) for each nucleus.
A same day WT control (+/- Lev) was analyzed for all genotypes. For terrier imaging ~6–10 worms
were immobilized on 10% agarose pads with 0.3 ml of 0.1 mm diameter polystyrene microspheres
and for each worm the closest neuromuscular junction to the surface was imaged. Worms were only
accepted for analysis if they had clearly identifiable red and green puncta. Both intensity and area
were analysed using FIJI.
Retinal plates
4 ml of all trans-retinal (ATR, 100 mM dissolved in ethanol) was mixed with 250 ml of OP50 E. coli and
spread on 60 mm NGM plates. Plates were allowed to dry for 24 hr and approx. 40 L4 animals were
added and allowed to grow in the dark for 16–24 hr before the assay. Control plates used 4 ml of
ethanol mixed with 250 ml of OP50.
Optogenetic stimulation
ACh release at NMJs was evoked in animals expressing the Channelrhodopsin variant ChIEF in cho-
linergic neurons (oxSi93) (Watanabe et al., 2013). Animals were photo-stimulated with seven 470
nm Rebel LEDs mounted on a 40 mm SinkPadII fitted with a Round Concentrator Lens and powered
with a 700 mA DC Driver (Luxeon Star LEDs). 20 min of 25 ms light pulses were generated at the
indicated frequencies using an Arduino Uno. Pulse frequency and duration were confirmed using a
photodiode and oscilloscope.
qPCR
Total RNA was purified from a synchronized population of young adult worms treated with 200 mM
Levamisole for 1 hr and mock-treated samples. RNA was isolated using standard Trizol-bromochloro-
propane extraction methods in combination with the Qiagen RNeasy Kit. RNA was DNase treated
using the Qiagen on-column RNase free DNase set. Samples were prepared from the following gen-
otypes: wild-type (N2 Bristol) and shn-1 (tm488) on two separate days. One micrograms of total
RNA was used to synthesize cDNA using RETROscript (Ambion). Real-time PCR was performed
using iTaq Universal SYBR Green Supermix (BioRad) and a 7500 Fast Real-Time PCR System (Applied
Biosystems). All reactions were run in triplicate and on at least two biological replicates. All the val-
ues are normalized to rpl-32 as internal control as well as to the transcript levels in untreated sam-
ples. Statistical significance was determined using the two-tailed Student’s t test.
Microarray analysis
RNA isolation and cDNA synthesis was performed as described for qPCR. 6 Affymetrix C. elegans
GeneChip were used (3  1 hr 200 mM Levamisole exposure and 3x mock-treated samples). Expres-
sion values were determined using the Robust Multi-chip Average (RMA) method. Probe sets that
showed a > 2 fold change between mock and levamisole treated, with an unadjusted p-value
of <0.0001 were considered to be Levamisole responsive. HLH-1 chip-seq data was taken from mod-
encode (http://www.modencode.org). The PWM used for analysis of crh-1 binding sites was from
Homer (http://homer.ucsd.edu/homer/).
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Electrophysiology
Whole-cell patch-clamp measurements were performed using a Axopatch 200B amplifier with
pClamp 10 software (Molecular Devices). The data were sampled at 10 kHz and filtered at 5 kHz. All
recordings were performed at room temperature (~19–21˚C)
Evoked EPSCs
Worms were superfused in an extracellular solution containing (in mM) 127 NaCl, 5 KCl, 26
NaHCO3, 1.25 NaH2PO4, 20 glucose, 1 CaCl2 and 4 MgCl2, bubbled with 5% CO2, 95% O2 at 20˚C.
Whole cell recordings were carried out at –60 mV using an internal solution containing 105 mM
CH3O3SCs, 10 mM CsCl, 15 mM CsF, 4 mM MgCl2, 5 mM EGTA, 0.25 mM CaCl2, 10 mM HEPES
and 4 mM Na2ATP, adjusted to pH 7.2 using CsOH. Under these conditions, we only observed
endogenous acetylcholine EPSCs. For endogenous GABA IPSC recordings the holding potential was
0 mV. All recording conditions were as described (McEwen et al., 2006). Stimulus-evoked EPSCs
were stimulated by placing a borosilicate pipette (5–10 mm) near the ventral nerve cord (one muscle
distance from the recording pipette) and applying a 0.4 ms, 30 mA square pulse using a stimulus cur-
rent generator (WPI).
Ca+2 current recordings
The pipette solution contained (in mM): 140 CsCl; 10 TEA-Cl; 5 MgCl2; 5 EGTA; 10 Hepes, pH 7.2,
with ~320 mosM CsOH. The extracellular solution contained (in mM): 140 TEA-Cl; 5 CaCl2; 1 MgCl2;
3 4-aminopyridine; 10 glucose; five sucrose; 15 Hepes, pH 7.4, with ~330 mosM CsOH. The voltage-
clamp protocol consisted of  60 mV for 50 ms,  90 mV for 50 ms, test voltage (from  60 mV to +4
mV) 200 ms. Access resistance was continuously monitored, and ranged between 7 and 15 MW.
Series resistance was not compensated. The voltage dependence of the Ca+2 current density were
fitted with the equation: I(V) = Gmax(V – Vrev) / ({1 + exp[(V0.5 – V) / k]}), where I(V) is the density of
the current measured, V is the test pulse, Gmax is the maximum conductance, Vrev is the apparent
reversal potential, V0.5 is the half-activation voltage, and k is a steepness factor. The decay tau was
well fit by a single exponential function and calculated from a test potential of 0 mV fitting the curve
from the peak of the current till the end of the pulse.
Gating currents
The pipet and bath solutions were as described for the calcium current recordings. To resolve gat-
ing currents leak and capacitive transients were subtracted using a p/4 protocol, and measured by
applying a series of test pulses at 5s intervals from the holding potential of  90 mV to potentials
between +40 mV and +50 mV in 2 mV increments and integrating the gating charge movement at
the reversal potential for the ionic current.
K+ current recordings
The bath solution contained (in mM): NaCl 140, KCl 5, CaCl2 5, MgCl2 5, dextrose 11 and HEPES 5
(pH 7.2, 320 mOsm); and the pipette solution contained (in mM): KCl 120, KOH 20, Tris 5, CaCl2
0.25, MgCl2 4, sucrose 36, EGTA five and Na2ATP 4 (pH 7.2, 323 mOsm). The voltage-clamp proto-
col consisted of  60 mV for 50 ms,  90 mV for 50 ms, test voltage (from  60 mV to +60 mV) 1000
ms. IKfast was defined as the peak current after the capacitance transients, and IKslow was defined as
the average current of the last 100 ms of each voltage step.
Statistics
Data was assessed for a normal distribution using the D’Agostino-Pearson normality test and equal-
ity of variances using the F-Test. For comparisons of normally distributed data with equal variances a
two-tailed Student’s t-test was used. For all other comparisons the Mann–Whitney U test was used.
For analysis of calcium current-voltage relationships, two-way ANOVA with Sidak’s correction for
multiple comparisons was utilized. All statistics were performed in GraphPad Prism 6 and significant
differences are indicated as follows: *p<0.05, **p<0.01, and ***p<0.001.
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